Jean Engels

Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis.

L. LaVange, R. Deterding, B. Ramsey, 2007, American journal of respiratory and critical care medicine.

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: Results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis

R. Gibson, L. LaVange, R. Deterding, 2005, Pediatric pulmonology.

Denufosol: a review of studies with inhaled P2Y(2) agonists that led to Phase 3.

D. Kellerman, A. Schaberg, J. Gorden, 2008, Pulmonary pharmacology & therapeutics.

Randomized clinical trial of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related PTSD and the role of sleep quality in treatment response

G. Sullivan, F. Weathers, B. Daugherty, 2021, Psychiatry Research.